Clinical trial

Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated…

NCT00074724 · Medstar Health Research Institute, Other · Completed

Key facts

NCT number NCT00074724
Title Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization
Official title Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization
Acronym DECIPHER
Lead sponsor Medstar Health Research Institute, Other
Collaborators National Heart, Lung, and Blood Institute (NHLBI) NIH
Status Completed
Study type Interventional
Conditions Cardiovascular Diseases, Coronary Disease, Heart Failure, Congestive, Heart Diseases
Intervention type Device, Drug, Procedure
Interventions Coronary Artery Bypass, Modern medical management, Dobutamine echocardiography, Optimal medical therapy
Enrollment 319
Start date May 1, 2003
Primary completion Dec 1, 2008
Completion Apr 1, 2017
First posted Dec 23, 2003
Last update posted Apr 8, 2021

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies